As of close of business last night, Aptevo Therapeutics Inc’s stock clocked out at $0.14, down -13.72% from its previous closing price of $0.16. In other words, the price has decreased by -$0.0225 from its previous closing price. On the day, 1841305 shares were traded. APVO stock price reached its highest trading level at $0.1548 during the session, while it also had its lowest trading level at $0.1301.
Ratios:
To gain a deeper understanding of APVO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.09 and its Current Ratio is at 3.09. In the meantime, Its Debt-to-Equity ratio is 0.38 whereas as Long-Term Debt/Eq ratio is at 0.38.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APVO now has a Market Capitalization of 3.57M and an Enterprise Value of -9.96M.
Stock Price History:
Over the past 52 weeks, APVO has reached a high of $2.24, while it has fallen to a 52-week low of $0.12. The 50-Day Moving Average of the stock is 0.1592, while the 200-Day Moving Average is calculated to be 0.5271.
Shares Statistics:
It appears that APVO traded 387.41K shares on average per day over the past three months and 668.33k shares per day over the past ten days. A total of 22.33M shares are outstanding, with a floating share count of 22.20M. Insiders hold about 0.61% of the company’s shares, while institutions hold 8.72% stake in the company. Shares short for APVO as of Feb 15, 2024 were 19.64k with a Short Ratio of 0.05, compared to 78.94k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.09% and a Short% of Float of 0.09%.
Earnings Estimates
As of right now, 2 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.41 for the current quarter, with a high estimate of -$0.37 and a low estimate of -$0.45, while EPS last year was -$0.95. The consensus estimate for the next quarter is -$0.36, with high estimates of -$0.36 and low estimates of -$0.36.
Analysts are recommending an EPS of between -$1.65 and -$1.78 for the fiscal current year, implying an average EPS of -$1.71. EPS for the following year is -$1.33, with 1 analysts recommending between -$1.33 and -$1.33.
